Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Baker Bros Advisors LP | 9.40M (498.84%) | 0.00 Increased by 0.00% | Sep 30, 24 |
2 | Deep Track Capital, LP | 3.55M (188.29%) | 57.49K Increased by +1.62% | Sep 30, 24 |
3 | Paradigm Biocapital Advisors LP | 3.25M (172.30%) | -460.24K Decreased by -14.18% | Mar 31, 24 |
4 | Morgan Stanley - Brokerage Accounts | 2.46M (130.71%) | -570.28K Decreased by -23.15% | Jun 30, 24 |
5 | RA Capital Management, LLC | 2.25M (119.56%) | 1.45M Increased by +64.49% | Jun 30, 24 |
6 | FCPM III SERVICES BV | 2.12M (112.66%) | 2.12M Increased by +100.00% | Jun 30, 24 |
7 | Armistice Capital, LLC | 1.97M (104.65%) | 300.00K Increased by +15.21% | Jun 30, 24 |
8 | Jefferies Financial Group Inc | 1.95M (103.38%) | 0.00 Increased by 0.00% | Dec 31, 23 |
9 | Westfield Capital Management Company, LP | 1.85M (98.23%) | 327.09K Increased by +17.67% | Sep 30, 24 |
10 | Tybourne Capital Management (HK) Ltd | 1.51M (80.12%) | -35.31K Decreased by -2.34% | Jun 30, 24 |
11 | First Light Asset Management, LLC | 1.38M (73.49%) | 191.72K Increased by +13.84% | Jun 30, 24 |
12 | Point72 Asset Management, L.P. | 1.30M (68.96%) | 821.50K Increased by +63.22% | Sep 30, 23 |
13 | BRAIDWELL LP | 1.29M (68.45%) | 1.29M Increased by +100.00% | Sep 30, 23 |
14 | Fairmount Funds Management LLC | 1.07M (56.74%) | 1.07M Increased by +100.00% | Jun 30, 24 |
15 | Polar Capital Holdings PLC | 1.00M (53.31%) | 0.00 Increased by 0.00% | Jun 30, 24 |
16 | Camber Capital Management LLC | 915.00K (48.56%) | 0.00 Increased by 0.00% | Sep 30, 24 |
17 | Suvretta Capital Management, LLC | 914.48K (48.53%) | 0.00 Increased by 0.00% | Mar 31, 24 |
18 | HHG PLC | 910.93K (48.34%) | -370.39K Decreased by -40.66% | Sep 30, 23 |
19 | EcoR1 Capital, LLC | 910.00K (48.29%) | 910.00K Increased by +100.00% | Jun 30, 24 |
20 | BNP Paribas Investment Partners SA | 888.08K (47.13%) | 4.98K Increased by +0.56% | Jun 30, 24 |
Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | T. Rowe Price Health Sciences | 1.33M (70.70%) | 33.87K Increased by +2.54% | Sep 30, 24 |
2 | Polar Capital Biotech S Inc | 1.00M (53.07%) | 0.00 Increased by 0.00% | Sep 30, 24 |
3 | Harbor Small Cap Growth Instl | 847.47K (44.97%) | 151.69K Increased by +17.90% | Sep 30, 24 |
4 | Westfield Capital Mgt Co Sm-Cap Gr Eq | 695.78K (36.92%) | 234.44K Increased by +33.69% | Jun 30, 24 |
5 | Candriam Eqs L Biotech C USD Cap | 558.46K (29.64%) | 103.02K Increased by +18.45% | Sep 30, 24 |
6 | BNP Paribas Health Cr Innovtr Cl Cap | 524.80K (27.85%) | -70.78K Decreased by -13.49% | Sep 30, 24 |
7 | Belfius Equities Cure C Cap | 492.11K (26.12%) | 0.00 Increased by 0.00% | Sep 30, 24 |
8 | Candriam Global Equities Oncology | 492.11K (26.12%) | 125.18K Increased by +25.44% | Sep 30, 24 |
9 | Janus Henderson Global Life Sciences | 385.75K (20.47%) | -89.69K Decreased by -23.25% | Sep 30, 23 |
10 | Janus Henderson Global Life Sciences D | 385.75K (20.47%) | -89.69K Decreased by -23.25% | Sep 30, 23 |
11 | Janus Selection Global Life Science AUSD | 298.27K (15.83%) | -76.67K Decreased by -25.71% | Sep 30, 23 |
12 | AXA Framlington Health R Inc | 279.70K (14.84%) | -8.49K Decreased by -3.03% | Nov 30, 23 |
13 | AXA Framlington Health Fund - R Income | 273.98K (14.54%) | 0.00 Increased by 0.00% | Sep 30, 24 |
14 | iShares Biotechnology ETF | 272.78K (14.48%) | -1.63K Decreased by -0.60% | Oct 31, 24 |
15 | UTM IM GBP AXA Framlington Biotech | 268.72K (14.26%) | 0.00 Increased by 0.00% | Sep 30, 24 |
16 | Fidelity Select Biotechnology | 266.35K (14.13%) | 0.00 Increased by 0.00% | Dec 31, 23 |
17 | Fidelity® Select Biotechnology | 266.35K (14.13%) | 0.00 Increased by 0.00% | Nov 30, 23 |
18 | BNP Paribas US Small Cap Classic R | 235.31K (12.49%) | -33.34K Decreased by -14.17% | Sep 30, 24 |
19 | Principal SmallCap R5 | 201.90K (10.71%) | 33.10K Increased by +16.39% | Sep 30, 24 |
20 | Principal U.S. Small Cap Equity | 201.90K (10.71%) | 201.90K Increased by +100.00% | Sep 30, 24 |